Scopus Asset Management’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.9M Buy
150,000
+100,000
+200% +$13.1M 0.31% 112
2025
Q4
$6.81M Buy
50,000
+25,000
+100% +$3.6M 0.11% 207
2025
Q3
$3.69M Sell
25,000
-24,200
-49% -$3.36M 0.05% 257
2025
Q2
$6.36M Buy
+49,200
New +$5.96M 0.11% 198
2024
Q4
Sell
-30,000
Closed -$4.05M 329
2024
Q3
$4.05M Hold
30,000
0.07% 240
2024
Q2
$4.07M Buy
+30,000
New +$4.08M 0.08% 188
2018
Q3
Sell
-100,000
Closed -$6.74M 351
2018
Q2
$6.74M Buy
100,000
+30,000
+43% +$2.18M 0.06% 234
2018
Q1
$5.38M Sell
70,000
-180,000
-72% -$13.3M 0.05% 237
2017
Q4
$17.1M Buy
+250,000
New +$16.6M 0.16% 165

Other funds holding XYL

Scopus Asset Management's XYL Position: Q1 2026 in Review

Scopus Asset Management reduced its Xylem (XYL) stake by 6.3% in Q1 2026, selling an estimated $1.31M and leaving 148,245 shares worth $17.7M. The position accounts for 0.31% of the portfolio, ranked #113.

Scopus Asset Management first reported a position in XYL in Q4 2015 and has held it in 19 quarters since. The position peaked at $30.1M in Q4 2017. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Scopus Asset Management held 148,245 shares of Xylem worth $17.7M as of Q1 2026.
  • Scopus Asset Management sold 10,026 Xylem shares in Q1 2026, an estimated $1.31M.
  • Xylem made up 0.31% of Scopus Asset Management's portfolio in Q1 2026, its #113 holding.
  • Scopus Asset Management first reported a position in Xylem in Q4 2015 and has held it in 19 quarters since.
  • Scopus Asset Management's Xylem position peaked at $30.1M in Q4 2017.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Scopus Asset Management's 13F filing for Q1 2026, filed 15 May 2026.